Summary
In this paper we discuss the theory that agoraphobic avoidances are central and spontaneous panics an epiphenomenon to the development of agoraphobia. Moreover we discuss the theory that posits a fixed cognitive-catastrophizing set as causal for panic. We conclude these theories do not fit the facts. We argue that it is important to distinguish between spontaneous panic and chronic or anticipatory anxiety and avoidance. Such a distinction allows for an understanding of the roles of anti-spontaneous panic medications such as tricyclics and MAOI's, as well as exposure therapy, in the treatment of panic disorder with agoraphobia. The former serves the purpose of blocking panic attacks while the latter undermines phobic avoidance, but only after the panic attacks have ceased through proper medication. We conclude that recognizing the key role of spontaneous panic and its variants in anxiety nosology is a necessary guide for etiological, psychophysiological and therapeutic research in this rapidly developing area.
Similar content being viewed by others
References
Adler C, Craske MG, Barton DH (1987) Relaxation-induced panic (RIP): When resting isn't peaceful. Integrat Psychiatry 5:94–112
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (3rd edn revised)
Angst J, Dobler-Mikola A (1985) The Zurich study: Anxiety and phobia in young adults. Eur Arch Psychiatr Neurol Sci 235:171–178
Argyle N, Roth M (1986) The relationship of panic attacks to anxiety states and depression. In: Biological psychiatry 1985: Proceedings of the IVth World Congress of Biological Psychiatry. Shagass C, Tosiassen RC, Bridger WH, Weiss KT, Stoff D, Simpson GM. Elsevier, Amsterdam, pp 460–462
Aronson TA, Logue CM (1987) On the longitudinal course over of panic disorder: Developmental history and predictors of phobic complications. Compr Psychiatry 28:344–455
Bowlby J (1969) Attachment and loss, vol I: Attachment. Basic Books, New York
Bowlby J (1973) Attachment and loss, vol II: Separation anxiety and anger. Basic Books, New York
Brantigan CO, Brantigan TA, Joseph N (1982) Effect of beta-blockade and beta-stimulation on stage fright. Am J Med 72:88–94
Breier A, Charney DS, Heninger GR (1985) The diagnostic validity of anxiety disorders and their relationship to depressive illness. Am J Psychiatry 142:787–797
Breier A, Charney DS, Heninger GR (1986) Agoraphobia with panic attacks: Development, diagnostic stability and course of illness. Arch Gen Psychiatry 43:1029–1036
Brown FW (1942) Heredity in the psychoneuroses. Proc Soc Med 35:785–790
Buigues J, Vallejo J (1987) Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks. J Clin Psychiatry 48:55–59
Burns LE, Thorpe GL (1977) The epidemiology of fears and phobias. J Int Med Res 5 : [Suppl 107]
Carey G, Gottesman II (1981) Twin and family studies of anxiety, phobic and obsessive disorders. In: Klein DF, Rabkin J (eds) Anxiety: new research and changing concepts. Raven Press, New York
Charney DS, Woods SW, Goodman WK, Kifkin B, Kinch M, Aiken B, Quadrino LM, Heninger G (1986) Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam and trazadone. J Clin Psychiatry 47:580–585
Clark DM (1986) A cognitive approach to panic. Behav Res Ther 24:461–470
Cloninger RC, Martin RL, Clayton P, Guze SB (1981) A blind follow-up and family study of anxiety neurosis: Preliminary analysis of the St. Louis 500. In: Klein DF, Rabkin J (eds) Anxiety: New research and changing concepts. Raven Press, New York, pp 137–154
Cloninger RC (1987) Recent advances in the genetics of anxiety and somatoform disorders. In: Meitzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York
Clum GA, Pendrey D (1987) Depression symptomatology as a non-requisite for successful treatment of panic with antidepressant medications. J Anxiety Dis 1:337–344
Cohen ME (1951) The high familial prevalence of neurocirculatory asthenia (anxiety neurosis, effort syndrome). Am J Hum Genet 3:126–158
Crowe RR (1985) The genetics of panic disorder and agoraphobia. Psychiatr Dev 2:171–186
Crowe RR, Noyes R, Pauls DL, Slymen D (1983) A family study of panic disorder. Arch Gen Psychiatry 40:1065–1069
Crowe RR, Noyes R, Wilson AF, Elston RC, Ward LJ (1987) A linkage study of panic disorder. Arch Gen Psychiatry 44:933–937
Freud S (1895) Obsessions and phobias; their psychical mechanisms and their aetiology. Collected papers, vol 1. (Translated by Riviere J) Hogarth Press, London 1924
Fyer AJ (1988) Discontinuation of antipanic medication. In: Hand I, Wittchen HV (eds) Panic and Phobia II. Springer, Berlin Heidelberg New York
Garakani H, Zitrin CM, Klein DF (1984) Treatment of panic disorder with imipramine alone. Am J Psychiatry 141:446–448
Garvey MJ, Tuason VB (1984) The relationship of panic disorder to agoraphobia. Compr Psychiatry 25:529–531
Gloger S, Grunhaus L, Pirmacher B, Troudart T (1981) Treatment of spontaneous panic attacks with chlomipramine. Am J Psychiatry 138:1215–1217
Gorman J, Levy GF, Liebowitz MR, McGrath P, Appleby IL, Dillon DJ, Davies SO, Klein DF (1983) The effect of acute beta-adrenergic blockade on lactate induced panic. Arch Gen Psychiatry 40:1079–1083
Gorman J, Askanazi J, Liebowitz MR, Fyer AJ, Stein J, Kinney JM, Klein DF (1984) Response to hyperventilation in a group of patients with panic disorder. Am J Psychiatry 141:857–861
Gorman JM, Fyer MR, Goetz R, Askanazi J, Liebowitz MR, Fyer AJ, Kinney J, Klein DF (1988) Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry 45:31–42
Grunhaus L, Gloger S, Branacker B, Palmer C, Ben-David M (1983) Prolactin response to the cold pressor test in patients with panic attacks. Psychiatr Res 8:171–177
Gurney C, Roth M, Garside RF, Kerr TA, Schapira K (1972) Studies in the classification of affective disorders. The relationship between anxiety states and depressive illness — II. Br J Psychiatry 121:162–166
Hafner J, Milton F (1977) The influence of propranolol on the exposure in vivo of agoraphobics. Psychol Med 7:419–425
Harris EL, Noyes R, Crower RR, Chaudhry DR (1983) Family study of agoraphobia. Arch Gen Psychiatry 40:1061–1064
Hartley LR, Ungapen S, Davie I, Spencer DJ (1983) The effect of beta-adrenergic blocking drugs on speakers' performance and memory. Br J Psychiatry 142:512–517
Hoehn-Saric R, McLeod DR (1985) Generalized anxiety disorder. Psychiatr Clin North Am 8:73–88
Johnstone EC, Owens Cunningham DG, Frith CD, MiPherson K, Dowie C, Riley G, Gold A (1980) Neurotic illness and it response to anxiolytic and antidepressant treatment. Psychol Med 10:321–328
Kahn RJ, McNair DM, Covi L, Downing RW, Fisher S, Lipman RS, Kickels K, Smith V (1981) Affects of psychotropic agents on high anxiety subjects. Psychopharmacol Bull 17:97–100
Kahn RJ, McNair DM, Lipman RS, Covi L, Rickels K, Douning R, Fisher S, Frankenthaler LM (1986) Imipramine and chloridiazepoxide in depressive and anxiety disorders: 2. Efficacy in anxious outpatients. Arch Gen Psychiatry 43:79–85
Katon W (1984) Panic disorder and somatization. Am J Med 77:101–106
Katon W, Vitaliano PP, Anduson K, Jones M, Russo J (1987) Panic Disorder: Residual symptoms after the acute attacks abate. Compr Psychiatry 28:151–158
Kelly D, Gvirquis W, Frommer E, Mitchell-Heggs N, Sargant W (1970) Treatment of phobic states with antidepressants: A retrospective study of 246 patients. Br J Psychiatry 116:387–398
Kelly D, Mitchell-Heggs N, Sherman D (1971) Anxiety and the effects of sodium lactate assessed clinically and physiologically. Br J Psychiatry 119:129–141
Kendler K, Heath A, Martin NG, Eaves LJ (1986) Symptoms of anxiety and depression in a volunteer twin population: the etiologic role of genetic and environmental factors. Arch Gen Psychiatry 43:213–221
Klein DF (1964) Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 5:397–408
Klein DF (1967) Importance of psychiatric diagnosis in prediction of clinical drug effects. Arch Gen Psychiatry 16:118–126
Klein DF (1973) Drug therapy as a means of syndromal identification and nosological revision. In: Cole JO, Freedman AM, Friedhof AJ (eds) Psychopathology and psychopharmacology. The John Hopkins Press, Baltimore, pp 143–160
Klein DF (1978) A proposed definition of mental illness. In: Spitzer R, Klein DF (eds) Critical issues in psychiatric diagnosis. Raven Press, New York, pp 41–71
Klein DF (1983) Is the antipanic acitvity of antidepressant medication a reflection of antidepressant effects? Integrat Psychiatry 1:26–27
Klein DF (1987) Anxiety reconceptualized. Gleaning from pharmacological dissection — early experience with imipramine and anxiety. In: Klein DF (ed) Anxiety. Karger, Basel
Klein DF, Fink M (1962) Psychiatric reaction patterns to imipramine. Am J Psychiatry 119:432–438
Klein DF, Ross DC, Cohen D (1987) Panic and avoidance in agoraphobia: Application of path analysis to treatment studies. Arch Gen Psychiatry 44:377–385
Klein DF, Mein HM (1988) The definition and psychopharmacology of spontaneous panic and phobia: A critical review I. In: Tyrer P (ed) Psychopharmacology of anxiety. Oxford University Press
Kleiner L, Marshall WL (1987) The role of interpersonal problems in the development of agoraphobia with panic attacks. J Anxiety Dis 1:313–323
Koenigsberg HW, Pollack C, Sullivan T (1987) The sleep lactate infusion. Arousal and the panic mechanism. Biol Psychiatry 22:789–791
Leckman JS, Weissman MM, Merikangas KR, Paulo DL, Prusoff BA (1983) Panic disorder and major depression: increased risk of major depression, alcoholism, panic and phobic disorders in families of depressed probands with panic disorder. Arch Gen Psychiatry 40:1055–1060
Liebowitz MR, Gorman JM, Fyer AJ, Levitt M, Dillon D, Levy G, Appleby IL, Anderson S, Palij M, Davies SO, Klein DF (1985) Lactate provocation of panic attacks: II. Biochemical and physiological findings. Arch Gen Psychiatry 42:709–719
Lipman RS, Covi L, Rickels K, McNair OM, Downing R, Kahn RJ, Lasseter VK, Faden V (1986) Imipramine and chlordiazepoxide in depressive and anxiety disorders: I. Efficacy in depressed outpatients. Arch Gen Psychiatry 43:68–77
Lydiard BR (1987) Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry 144:664–665
Mann JJ, Aarons SF, Frames AJ, Brown RD (1984) Studies of selective and reversible monoamine oxidase inhibitors. J Clin Psychiatry 45:62–66
Marks IM (1983) Are there anticompulsive or antiphobic drugs? Review of the evidence. Br J Psychiatry 143:338–347
Marks IM (1987) Fears, phobias and rituals: Panic, anxiety and their disorders. Oxford University Press, Oxford
Mavissakalian M, Michelson L, Dealy RS (1983) Pharmacological treatment of agoraphobia: Imipramine vs. imipramine with programmed practice. Br J Psychiatry 143:348–355
McInnes RG (1937) Observations on heredity and neurosis. Proc R Acad Med 30:895–904
McNair DM, Kahn RJ (1981) Imipramine compared with a benzodiazepine for agoraphobia. In: Klein DF, Rabkin J (eds) Anxiety: New research and changing concepts. Raven Press, New York
Mendel JGC, Klein DF (1969) Anxiety attacks with subsequent agoraphobia. Compr Psychiatry 10:190–195
Modigh K (1987) Antidepressant drugs in anxiety disorders. Acta Psychiatr Scand 76[Suppl 335]:57–73
Mountjoy CQ, Roth M, Garside RF, Leitch IM (1977) A clinical trial of phenelzine in anxiety depressive and phobic neuroses. Br J Psychiatry 131:486–492
Munjack DJ, Rebal R, Shaner R, Staples F, Braun R, Leonard M (1985) Imipramine vs propranolol for the treatment of panic attacks: A pilot study. Compr Psychiatry 26:80–89
Muskin PR, Fyer AJ (1981) Treatment of panic disorder. J Clin Psychopharmacol 1:81–90
Neftel KA, Adler RH, Kappeli L, Rossi M, Dolder M, Käser HE, Bryggesser HH, Vorkauf H (1982) Stage fright in musicians: A model illustrating the effect of beta-blockers. Psychosom Med 44:461–469
Norton GR, Hamson B, Hauch J, Khodes L (1985) Characteristics of people with infrequent panic attacks. J Abnorm Psychol 94:216–221
Noyes R, Clancy J, Crowe R, Hoenk PR, Slymen DJ (1978) The familial prevalence of anxiety neurosis. Arch Gen Psychiatry 35:1057–1059
Noyes R (1984) Diazepam and propranololin panic disorder and agoraphobia. Arch Gen Psychiatry 41:287–292
Noyes R, Crowe RR, Harris EL, Haura BJ, McChesney CM, Chandhry DR (1986) Relationship between panic disorder and agoraphobia: a family study. Arch Gen Psychiatry 43:227–232
Noyes R, Clarkson C, Crowe RR, Yates WR, McChesney CM (1987a) A family study of generalized anxiety disorder. Am J Psychiatry 144:1019–1024
Nurnberg HG, Coccaro EF (1982) Response of panic disorder and resistance of depression to imipramine. Am J Psychiatry 139:1060–1062
Nutt DJ (1986) Increased central alpha2-adrenoceptor sensitivity in panic disorder. Psychopharmacology 90:268–269
Pauls DF, Bucher KD, Crowe RR, Noyes R (1980) A genetic study of panic disorder pedigrees. Am J Hum Genet 32:639–644
Pitts FN, Allen RE (1979) Biochemical induction of anxiety. In: Fann WE (ed) Phenomenology and treatment of anxiety. Medical and Scientific Books, New York, pp 125–140
Roth M, Gurney C, Garside RF, Kerr TA (1972) Studies in the classification of affective disorders. The relatioship between anxiety states and depressive illnesses. Br J Psychiatry 121:147–161
Roy-Byrne P, Uhde TW, Post RM, King AC, Buchsbaum MS (1985) Normal pain sensitivity in patients with panic, disorder. Psychiatry Res 14:75–82
Roy-Byrne P, Uhde TW, Post RM (1986) Effect of one night's sleep deprivation on mood and behavior in panic disorder. Arch Gen Psychiatry 43:895–899
Schweizer E et al., Winokur A, Rickels K (1986) Insulin-induced hypoglycemia and panic attacks. Am J Psychiatry 143:654–655
Sheehan DV, Ballenser J, Jacobsen G (1980) Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Arch Gen Psychiatry 37:51–59
Sheehan DV, Davidson J, Manschreck T, Van Wyck Fleet J (1983) Lack of efficacy of new antidepressant (bupropion) in the treatment of panic disorder with phobias. J Clin Psychopharmacol 3:28–31
Sheehan DV, Ballenger J, Jacobsen G (1980) Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Arch Gen Psychiatry 37:51–59
Slater E, Shields J (1969) Genetical aspects of anxiety. Br J Psychiatry (special publication) 3:62–71
Teasdale J (1988) Cognitive models and treatments for panic: A critical evaluation. In: Rachmann S, Maser JD (eds) Panic: Psychological Perspectives. Hillsdale, N. J.: Lawrence Erlbaum Assoc
Telch MJ, Agras WS, Taylor CB, Roth WT, Gallen CC (1985) Combined pharmacological and behavioral treatment for agoraphobia. Behav Res Ther 23:325–335
Thyer BA, Himle J (1985) Temporal relationship between panic attack onset and phobic avoidance in agoraphobia. Behav Res Ther 23:607–608
Thyer BA, Himle J (1987) Phobic anxiety and panic anxiety: How do they differ? J Anx Dis 1:59–67
Thyer BA, Himle J, Curtis GC, Cameron OG, Nesse RM (1985) A comparison of panic disorder an agoraphobia with panic attacks. Compr Psychiatry 26:208–214
Torgersen S (1983) Genetic factors in anxiety disorders. Arch Gen Psychiatry 40:1085–1089
Torgersen S (1985) Hereditary differentiation of anxiety and affective neuroses. Br J Psychiatry 146:530–534
Tyrer P (1973) A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety. Psychopharmacologia (Berl) 32:237–254
Tyrer P, Gardner M, Lambourn J, Whitford M (1980) Clinical and pharmacokinetic factors affecting response to phenelzine. Br J Psychiatry 136:359–365
Tyrer P (1986) Classification of anxiety disorders: A critique of DSM-III. J Affective Dis 11:99–104
Uhde T, Boulenger JP, Roy-Byrne PP, Geraci MF, Vittone BJ, Post RM (1985) Longitudinal course of panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 9:39–51
Uhde T, Vittone BJ, Post RM (1984) Glucose tolerance testing in panic disorder. Am J Psychiatry 141:1461–1463
Weissman MM, Leaf BJ, Blazer DG, Boyd JH, Florio L (1986) Panic disorder: clinical, characteristics, epidemiology and treatment. Psychopharmacol Bull 22:787–791
Woods SW, Charney DS, McPherson GA, Gradman AH, Heninger GR (1987) Situational panic attacks: Behavioral; physiologic and biochemical characterization. Arch Gen Psychiatry 44:365–375
World Health Organization, ICD-10, Draft of Chapter V. Categories F00-1799: Mental, behavioural and developmental disorders, clinical descriptions and diagnostic guidelines (June 1987 draft for field trials), Geneva, 1987
Zitrin CM, Klein DF, Woerner MG (1978) Behavior therapy, supportive psychotherapy, imipramine, and phobias. Arch Gen Psychiatry 35:307–316
Zitrin CM, Klein DF, Woerner MG (1980) Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psychiatry 37:63–72
Zitrin CM, Klein DF, Woerner MG, Ross DC (1983) Treatment of phobias. 1. Comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 40:125–138
Zajonc RB (1984) On the primacy of affect. Am Psychol 39:117–123
Author information
Authors and Affiliations
Additional information
Parts of this article were presented on the occasion of the inauguration ceremony of the Department of Psychiatry of the University of Mainz on April 2 and 3, 1987
Rights and permissions
About this article
Cite this article
Klein, D.F., Klein, H.M. The utility of the panic disorder concept. Eur Arch Psychiatr Neurol Sci 238, 268–279 (1989). https://doi.org/10.1007/BF00449808
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00449808